Recent News

• 05.19.2025 - Climb Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
• 05.19.2025 - Climb Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
• 05.14.2025 - Climb Bio Reports First Quarter 2025 Financial Results and Provides Business Updates
• 05.14.2025 - Climb Bio Reports First Quarter 2025 Financial Results and Provides Business Updates
• 04.10.2025 - 24th Annual Needham Virtual Healthcare Conference
• 04.10.2025 - 24th Annual Needham Virtual Healthcare Conference
• 04.01.2025 - Climb Bio Appoints Seasoned Biotech Leaders to Board of Directors
• 04.01.2025 - Climb Bio Appoints Seasoned Biotech Leaders to Board of Directors
• 04.01.2025 - Climb Bio Appoints Seasoned Biotech Leaders to Board of Directors

Recent Filings

• 05.14.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.14.2025 - 8-K Current report
• 05.14.2025 - EX-99.1 EX-99.1
• 04.25.2025 - DEF 14A Other definitive proxy statements
• 04.25.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.25.2025 - ARS Annual Report to Security Holders
• 04.01.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.01.2025 - 3 Initial statement of beneficial ownership of securities
• 04.01.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.01.2025 - S-8 Securities to be offered to employees in employee benefit plans